Seboquiro, Erline Jhyl M.
HRN: 22-23-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2022
METRONIDAZOLE 500MG (TAB)
11/21/2022
11/28/2022
PO
500mg
Q8
S/P NSD; Thickly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes